Combatting allergic rhinitis-Why prefer Fexofenadine - Montelukast over Bilastine-Montelukast? dr. Abhimanyu Uppal9 Nov 2021 12:31 PM ISTWith the COVID restrictions getting unlocked in almost all states of India along with the approaching season of allergies, physicians across the...
Antiviral drug Molnupiravir: The next big thing for COVID-19 treatment? Dr. Kamal Kant Kohli29 Oct 2021 10:29 AM ISTNew Delhi: In a major development in the world's battle against the COVID-19 pandemic, an oral drug has shown positive results in reducing both...
Casirivimab-Imdevimab Treatment in Mild to Moderate COVID-19: A Real-World Evidence Dr. Kamal Kant Kohli19 Oct 2021 12:00 PM ISTCasirivimab and Imdevimab are two non-competing, high-affinity human IgG1 anti-SARS- CoV-2 monoclonal antibodies that bind non-competitively to the...
Promising Benefits of Nintedanib in Minimizing COVID Induced Lung Injury in mechanically ventilated patients: Results from a Pilot Study Dr. JUDO JOSEPH VACHAPARAMBIL11 Sept 2021 12:45 PM ISTNew Delhi: The COVID-19 pandemic has been unrelenting for the last year and a half. Globally, increasing numbers are added each day to the COVID-19...
Physician's choice of antihistaminic-leukotriene antagonist combination: An evidence-based comparison of montelukast-fexofenadine versus montelukast- levocetirizine dr. Abhimanyu Uppal8 Sept 2021 12:12 PM ISTNew Delhi: The pandemic restrictions are unlocking amid the looming fear of a 3rd COVID wave at this year's end. Physicians need to be aware and...
Amoxicillin in Paediatric Respiratory Infections - Review of Evidences Dr. Kamal Kant Kohli26 July 2021 9:00 AM ISTRespiratory Infections among Indian Children- Overview & ChallengesAcute respiratory infections (ARIs) are the leading cause of morbidity and...
New updates in COVID-19 research: Emerging therapeutic role of Fexofenadine and Montelukast. dr. Abhimanyu Uppal10 July 2021 11:17 AM ISTThe dawn of the year 2020 witnessed the surge of one of the biggest pandemics known to mankind. COVID-19 spread through continents affecting millions...
New York Study Shows Doxycycline Treatment effective in high-risk COVID patients dikshateckchandani9 Jun 2021 9:41 AM ISTThe SARS-CoV-2 infection continues to evolve with limited therapeutic options with the vaccine seemingly a few months still away. (1) In the...
Doxycycline Treatment in high-risk COVID patients: Recent Evidence Dr. Kamal Kant Kohli7 Jun 2021 3:37 PM ISTThe SARS-CoV-2 infection continues to evolve with limited therapeutic options with the vaccine seemingly a few months still away. (1) In the...
Post Covid-19 Recovery - Incidence of Pulmonary Sequelae - Hype or Fact? Dr Sravan Kumar4 Jun 2021 12:30 PM ISTCoronavirus disease 2019 (COVID-19) announced in March 2020 as a pandemic by the World Health Organization (WHO) with the causative agent of COVID-19...
Doxycycline - Comparative Review with Other Commonly Used Antibiotics In Clinical Practice in India ARVIND PANCHOLIA3 Jun 2021 12:45 PM ISTDoxycycline is a water-soluble tetracycline antibiotic, possesses bactericidal and bacteriostatic activity against a wide spectrum of gram-positive ...
Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease (NAFLD)-Clinical Implications Hina Zahid22 May 2021 9:15 AM ISTIntroduction: Obstructive sleep apnea (OSA) syndrome is a common sleep disorder and is characterized by episodes of complete or partial airway...
